Rochester, Minn.-based Mayo Clinic launched Mayo Clinic Platform_Orchestrate, a program aimed at helping biopharma and medical device companies accelerate clinical development.
The program offers collaborators access to Mayo Clinic’s de-identified clinical data, advanced AI tools, physician-scientist expertise and international partner network. The goal is to streamline the transition from discovery to delivery by removing traditional development barriers, according to an Oct. 1 news release from the health system.
Mayo Clinic Platform_Orchestrate integrates three core areas: discovery through real-world data and biospecimens, validation of AI models and digital tools, and deployment via scalable infrastructure. The initiative also leverages Mayo Clinic’s growing global network to support multimodal AI innovation and clinical trial recruitment.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
